NewAmsterdam Pharma financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

뉴암스테르담 파머NASDAQ:NAMS · Nasdaq · Healthcare

$23.20-3.97%

2026-10-02 close

NewAmsterdam Pharma's published financial data is dated 2026-10-04. 2024 revenue was $46M. 2024 operating profit was −$176M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy